Mergers & Acquisitions - Biotechnology

Filter

Current filters:

Biotechnology

Popular Filters

126 to 150 of 251 results

Oculus Innovative Sciences plan to spin off biotechnology business

13-01-2013

USA-based health care company Oculus Innovative Sciences (Nasdaq: OCLS) last week announced that its…

BiotechnologyMergers & AcquisitionsMicrocynOculus Innovative SciencesRUT58-60Ruthigen

2012 again a bumper year for Pharma M&A, but values well down

09-01-2013

The year 2012 was again a bumper year for merger and acquisition activity in the global pharmaceutical,…

BiotechBiotechnologyGenericsMergers & AcquisitionsPharmaceutical

Shire to acquire Lotus Tissue Repair for undisclosed price

09-01-2013

Ireland-headquartered drugmaker Shire (LSE: SHP) said yesterday that it has signed an agreement to acquire…

BiotechnologyLotus Tissue RepairMergers & AcquisitionsPharmaceuticalRare diseasesShire

Big pharma will increasingly tap M&A to close $100 billion growth gap

07-01-2013

Big pharma companies are facing a widening "growth gap" that will increase pressure to drive growth through…

BiotechnologyFinancialMergers & AcquisitionsPharmaceutical

Pharmaceutical M&A deals in 2012

07-01-2013

Details for the 131 M&A announcements in 2012 recorded by The Pharma Letter are provided in the full…

BiotechGenericsMergers & AcquisitionsPharmaceutical

Evotec acquires Cell Culture Service GmbH; expands deal with AstraZeneca

07-01-2013

German biotech firm Evotec (EVT: TecDAX) has acquired all the shares in Cell Culture Service GmbH (CCS),…

AstraZenecaBiotechnologyCell Culture Service GmbHDiabetesEvotecLicensingMedImmuneMergers & AcquisitionsPharmaceutical

Questcor Pharmaceuticals to acquire BioVectra for around $50 million

04-01-2013

California, USA-based Questcor Pharmaceuticals (Nasdaq: QCOR) has signed a definitive agreement to acquire…

BiotechnologyBioVectraGenericsMergers & AcquisitionsPharmaceuticalProductionQuestor Pharmaceuticals

American Capital commits $212 million to acquire Cambridge Major Laboratories

03-01-2013

Private equity firm American Capital (Nasdaq: ACAS) says that it has committed $212 million in the buyout…

American CapitalBiotechnologyCambridge Major LaboratoriesGenericsMergers & AcquisitionsPharmaceutical

Vivalis and Intercell announce "merger of equals"

18-12-2012

French biotech firm Vivalis (Euronext: VLS) has entered into an accord to acquire Intercell (ICEL.VI)…

BiotechnologyIntercellMergers & AcquisitionsVaccinesValnevaVivalis

Enzon mulls sale of company; Bio-Rad to acquire business from MorphoSys

18-12-2012

USA-based Enzon Pharmaceuticals (Nasdaq: ENZN) said yesterday that its board has retained Lazard to act…

Bio-Rad LaboratoriesBiotechnologyEnzon PharmaceuticalsMergers & AcquisitionsMorphoSys

Fresenius Kabi sells respiratory homecare business in France

17-12-2012

Germany-based Fresenius Kabi, a provider of infusion therapy and clinical nutrition. has signed an agreement…

BiotechnologyFresenius BiotechFresenius KabiMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Gilead agrees to buy YM BioSciences for $510 million

13-12-2012

US biotech firm Gilead Sciences (Nasdaq: GILD) has agreed to acquire Canada's YM BioSciences (TSX: YM)…

BiotechnologyCYT387Gilead SciencesMergers & AcquisitionsOncologyPharmaceuticalYM Biosciences

Amgen paying $415 to acquire deCODE Genetics

11-12-2012

In what has been a busy M&A period for US biotech giant Amgen (Nasdaq: AMGN), the company has entered…

AmgenBiotechnologydeCODE GeneticsMergers & AcquisitionsPharmaceutical

Geron signs tentative deal with BioTime on stem cell assets

18-11-2012

A year after announcing its decision to exit stem cell therapy, the USA's Geron Corp (Nasdaq: GERN) has…

BiotechnologyBioTimeFinancialGeron CorpMergers & Acquisitions

Synthetic Biologics to acquire clinical-stage C. diff infectious disease program

12-11-2012

USA-based Synthetic Biologics (NYSE: SYN), a developer of synthetic biologics and innovative medicines…

Antibiotics and Infectious diseasesBiotechnologyMergers & AcquisitionsPrev AbRSYN-004Synthetic Biologics

Almirall expands in personalized medicine with 5% equity stake in AB-Biotics

24-10-2012

Spain's largest pharma company Almirall (ALM.MC) says it has reached an agreement with the Spanish biotech…

AB-BioticsAlmirallBiotechnologyMergers & AcquisitionsPharmaceuticalResearch

Pharmaceutical M&A activity declining slightly, reports Irving Levin Associates

21-10-2012

A new five-and-a-half year pharmaceutical merger and acquisition report published by Irving Levin Associates…

BiotechnologyMergers & AcquisitionsPharmaceutical

Celgene in deal with PharmAria, including an acquisition option

16-10-2012

Recently-formed drug discovery company PharmAria has entered into an agreement with US biotech firm Celgene…

BiotechnologyCelgeneMergers & AcquisitionsOncologyPharmAriaResearch

Australia's Benitec to acquire US RNAi firm Tacere

15-10-2012

Australia-based Benitec Biopharma (ASX: BLT) said last Friday that it has executed an agreement to acquire…

Anti-viralsBenitec BiopharmaBiotechnologyMergers & AcquisitionsPharmaceuticalTacere Therapeutics

126 to 150 of 251 results

Back to top